Merck Animal Health launches Nobivac NXT rabies vaccines for dogs and cats in the US
EN
eFeedLink Newsdesk
The non-adjuvanted vaccines offer one-year or three-year protection in a 0.5 mL dose for healthy dogs and cats from 12 weeks of age.
Related Articles
New Zealand's Cadmus Animal Health raises NZ$8 million for canine periodontal disease programme
15 Oct 2026
Boehringer Ingelheim introduces quarterable Previcox tablets for dogs after FDA approval
14 Oct 2026
Indonesia and WHO set zoonosis priorities for rabies, anthrax and leptospirosis hotspots
14 Oct 2026